Year: 2026
Type: preprint
Abstract: Human fetal haematopoiesis requires developmental potential to be encoded before lineage identity becomes transcriptionally apparent, but whether three-dimensional genome architecture provides such information is unknown. Here we develop ChromE-seq, a scalable single-cell assay that jointly profiles chromatin conformation and transcription, and integrate it with chromatin accessibility and DNA methylation to generate a multimodal atlas of ∼400,000 haematopoietic cells from disomic and trisomy 21 (T21) human fetal liver. Chromatin contacts frequently preceded lineage-specific transcription or persisted after transcription declined, revealing 3D chromatin priming and memory. Unexpectedly, B-lineage and erythroid differentiation followed opposing architectural trajectories, with progressive loss and gain of chromatin connectivity, respectively. T21 disproportionately disrupted B-lineage architecture, redistributed interactions towards shorter genomic distances and weakened an EBF1-centred regulatory circuit. Deletion of a T21-sensitive EBF1 loop anchor reproduced the CLP-to-B-progenitor bottleneck observed in T21. These findings establish 3D genome architecture as an organizing layer of human fetal haematopoiesis that links developmental potential with lineage-specific vulnerability to genomic perturbation. Highlights A ∼400,000-cell multimodal atlas resolves human fetal haematopoietic genome regulation 3D chromatin encodes developmental priming and persistence Trisomy 21 selectively disrupts B-lineage genome architecture A T21-sensitive EBF1 loop is required for normal B-cell development
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: Leukemia and Lymphoma Society, Icahn School of Medicine at Mount Sinai, Georgia Clinical and Translational Science Alliance, His Majesty’s Trust Fund, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Advancing Translational Sciences
Awards: G1359611882, G1493670431, G2276468959, G537743157, G6177305277, G7358338142, Reprogramming of myelopoiesis by DNMT3A mutation in lung cancer, Conduits: Mount Sinai Health System Translational Science Hub, Intrinsic and Extrinsic Factors Contributing to Trisomy 21 Preleukemia, Skin Biology and Diseases Resource-based Center at Mount Sinai, Mount Sinai Medical Scientist Training Program, The Tisch Cancer Institute - Cancer Center Support Grant, G9001303832
OpenAlex ID: W7221436937
